Bioequivalence and Bioavailability Forum

BE study for Minoxidil jag009 2025-02-20 06:24
- FDA PSGs: Alternative approach Helmut 2025-02-20 10:44
- BE study for Minoxidil drgunasakaran1 2025-02-21 00:57
  - BE study for Minoxidil jag009 2025-03-01 03:20
    - BE study for Minoxidil ElMaestro 2025-03-01 20:29

Question about Williams Design Bebac user 2025-02-25 20:30

different ranks/levels of William design? Shuanghe 2025-02-12 00:46
- different ranks/levels of William design? BEQool 2025-02-19 11:34
- "ranking" William designs mittyri 2025-02-19 21:08
  - "ranking" William designs vezz 2025-02-20 14:23
  - "ranking" William designs Shuanghe 2025-02-23 11:47

Bioequivalence studies for GCC submission professionalr 2025-01-30 23:00
- Bioequivalence studies for GCC submission drgunasakaran1 2025-01-31 03:20

Stratified randomisation in parallel BE studies and ANOVA model BEQool 2024-11-14 12:42
- Stratified randomisation in parallel BE studies BEQool 2025-01-27 08:03

Tripolidine BE Study – Malaysian RLD professionalr 2025-01-21 22:19
- ASEAN BE Guideline Helmut 2025-01-22 11:40

Interim Safety Analysis or Re-Screening professionalr 2025-01-09 22:56
- Interim Safety Analysis or Re-Screening drgunasakaran1 2025-01-10 00:01

Do regulatory agencies accept steady-state equivalence studies? libaiyi 2024-12-04 08:34
- HVD(P)s: steady state = history Helmut 2024-12-04 09:37
  - HVD(P)s: steady state = history libaiyi 2024-12-04 09:52
    - HVD(P)s: steady state = history dshah 2024-12-05 07:22
- Do regulatory agencies accept steady-state equivalence studies? xtianbadillo 2024-12-16 20:59
  - steady-state in patients Helmut 2024-12-17 09:45
    - steady-state in patients qualityassurance 2025-01-09 10:59

Possible reasons for group effect GM 2019-07-20 07:36
- Group “effect” Helmut 2019-07-20 14:02
- Possible reasons for group effect ElMaestro 2019-07-20 19:20
  - Possible reasons for group effect GM 2019-07-23 06:23
    - “Group-by-Treatment Interaction” Helmut 2019-07-23 10:32
      - “Group-by-Treatment Interaction” BEQool 2024-10-22 12:39
        
        “Group-by-Treatment Interaction” Helmut 2024-10-22 12:47
        
        OT: A choice between mittyri 2024-10-22 16:03
        
        OT: A choice between BEQool 2024-10-23 11:02
        
        OT: A choice between Helmut 2024-10-23 11:58
        
        OT: A choice between BEQool 2024-10-23 13:17
        
        OT: A choice between Helmut 2024-10-23 13:22
        Groups: Overlapping CIs Helmut 2024-11-03 11:36
        
        Groups: Overlapping CIs BEQool 2024-11-05 09:14
        
        Groups: Overlapping CIs Helmut 2024-11-05 10:12
        
        Groups: Overlapping CIs BEQool 2024-11-06 07:44
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-21 13:20
        
        Groups: (Hardly‽) overlapping CIs BEQool 2024-11-22 12:32
        
        Groups: (Hardly‽) overlapping CIs Helmut 2024-11-22 12:58
        Multiplicity? Helmut 2024-11-23 13:05
        
        Groups BEQool 2024-11-26 08:15

PK Sampling Time Points - SR Formulation TitusBen 2024-10-17 05:40
- PK Sampling Time Points - SR Formulation Helmut 2024-10-17 10:56
  - PK Sampling Time Points - SR Formulation TitusBen 2024-10-18 06:24
    - PK Sampling Time Points - DR Formulation Helmut 2024-10-18 09:16
      - PK Sampling Time Points - DR Formulation TitusBen 2024-10-18 16:45
        
        lag-time – another round Helmut 2024-10-19 08:20

Sulfasalazine: Bioequivalence Study ramesh_7779 2011-06-25 10:54
- Sulfasalazine: Bioequivalence Study Helmut 2011-06-25 13:18
  - Sulfasalazine: Bioequivalence Study dshah 2024-10-15 06:05
    - Sulfasalazine: Sources Helmut 2024-10-15 09:03
      - Sulfasalazine: Sources dshah 2024-10-16 06:16

risperidone AND water Bebac user 2024-09-04 18:51
- ODT vs IR Helmut 2024-09-05 11:57
- risperidone AND water dshah 2024-09-06 06:15

Compound highly variable Laura Carreiras 2024-08-28 08:20
- Always full (!) replicate pilot for reference-scaling Helmut 2024-08-28 11:25
  - Always full (!) replicate pilot for reference-scaling Laura Carreiras 2024-09-02 13:52

Leuprolide 1 month product shelf life Achievwin 2024-08-27 02:47

Oxcarbazepine Tablet Study design AB661 2024-07-13 09:02
- ABE or ABEL for Health Canada Helmut 2024-07-14 12:17
- Oxcarbazepine Tablet Study design jag009 2024-07-23 19:50
  - Health Canada ABEL Helmut 2024-07-24 09:06
  - Oxcarbazepine Tablet Study design AB661 2024-08-24 11:00
    - Oxcarbazepine Tablet Study design Helmut 2024-08-24 12:19

Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
29 visitors (0 registered, 29 guests [including 12 identified bots]).
Forum time: 20:25 CEST (Europe/Vienna)

Truth and clarity are complementary. Niels Bohr

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz